Hikma Pharmaceutical reported 873M in Operating Expenses for its first fiscal semester of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
AstraZeneca AZN:LN 11.54B 4.45B
Bayer BAYN:GR 9.25B 3.88B
Fresenius FRE:GR 8.32B 91M
Fresenius Medical Care FMS:US 3.94B 40.05M
Galapagos GLPG:NA 155.17M 44.65M
Genmab GEN:DC 1.42B 235M
GlaxoSmithKline GSK:LN 7.14B 722M
GRIFOLS GRF:SM 1.1B 129.52M
H. Lundbeck A/S LUN:DC 3.49B 123M
Hikma Pharmaceutical HIK:LN 873M 27M
Lonza Group LONN:SW 2.22B 1.07B
Merck MRK:GR 3.93B 105M
Orion ORNBV:FH 183.6M 300K
Recordati REC:IM 262.8M 2.28M